Posts in category: Uncategorized

The Organoid Group (Hubrecht Institute) and the Rare Cancers Genomics Team (IARC/WHO) found a way to grow samples of different types of neuroendocrine tumors (NETs) in the lab. While generating their new model, the researchers discovered that some pulmonary NETs need the protein EGF to be able to grow. These types of tumors may, therefore, be treatable using inhibitors of the EGF receptor. The results were published in Cancer Cell on 11 December 2023.

Doctors near Pittsburgh, Pennsylvania, have noticed a surge in patients coming into hospitals with RSV, a common virus with cold-like symptoms.

It has likely happened to everyone at some point: You are poised to go to sleep, but instead a “digital distraction” keeps you up hours later than you had planned.

Considerable geographic variability is seen in county-level preterm birth rates, according to a study published online Dec. 8 in JAMA Network Open.

On the cusp of summer holidays, Aussie kids are looking forward to some well-deserved time off. But too much downtime could create health problems, as new research shows that holidays are the prime time for excessive weight gain in kids.

By Annita Nc’ube

CRUSHERS and Edible Refiners Association Director Aubrey Chibumba says Zambia’s sunflower industry has suffered due to a lack of investment in research and development.

Colorado officials say their plan to import cheaper medicines from Canada has been stymied by opposition from drugmakers and inaction by the Biden administration, according to a state report obtained by KFF Health News.

Australian researchers have flagged potential concerns over the use of social chatbots, calling for more studies into the impact of the AI software on neurodiverse people and those who find human interaction difficult.

Immune cells fight infectious intruders, for example, or search for incipient cancers. Therefore, they are constantly migrating through the tissues of our body. But in the wrong place, immune cells like neutrophil granulocytes can cause damage. If these white blood cells infiltrate tumors, this is often associated with a poor prognosis for patients. This is why they could benefit from drugs that prevent neutrophils from migrating into tumors.

Changes in small blood vessels are a common consequence of diabetes development. Researchers at the Technical University of Munich (TUM) and Helmholtz Munich have now developed a method that can be used to measure these microvascular changes in the skin—and thus assess the severity of the disease. To achieve this, they combine artificial intelligence (AI) and innovative high-resolution optoacoustic imaging technology. The work is published in the journal Nature Biomedical Engineering.